Hongyun Biotech

Provider of therapeutics solution for the treatment of cancer and other rare diseases

placeNanjing, Jiangsu, China calendar_todayFounded 2018 language redcloudbio.com

Innovation

7 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 99 times.

YearFilings
20181
20191
20201
20214
20222
20234
20241
20251

Investor mix

6 investors on record.

Investor typeCountShare
Venture capital467%
Private equity117%
Other / undisclosed117%
Coming soon